Triple combination antiviral drug (TCAD) composed of amantadine, oseltamivir, and ribavirin impedes the selection of drug-resistant influenza A virus.
Widespread resistance among circulating influenza A strains to at least one of the anti-influenza drugs is a major public health concern. A triple combination antiviral drug (TCAD) regimen comprised of amantadine, oseltamivir, and ribavirin has been shown to have synergistic and broad spectrum activ...
Збережено в:
| Автори: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Public Library of Science (PLoS)
2011-01-01
|
| Серія: | PLoS ONE |
| Онлайн доступ: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0029778&type=printable |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|